PYRAZOLINE DERIVATIVES: A WORTHY INSIGHT INTO THE RECENT ADVANCES AND POTENTIAL PHARMACOLOGICAL ACTIVITIES

  • Md. Azizur Rahman Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Integral University, Lucknow(Uttar Pradesh 226026, India
  • Anees A. Siddiqui Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Jamia Hamdard (Hamdard University), New Delhi 110062, India

Abstract

2-Pyrazolines display a broad spectrum of potential pharmacological activities and are present in a number of pharmacologically active molecules such as phenazone/ amidopyrene/ methampyrone (analgesic and antipyretic), azolid/ tandearil (anti-inflammatory), indoxacarb (insecticide) and anturane (uricosuric). Changes in their structure have offered a high degree of diversity that has proven useful for the development of new therapeutic agents having improved potency and lesser toxicity. In this context, the recently synthesized 2-pyrazoline derivatives possessing important pharmacological activities have been highlighted.

Keywords: 2-Pyrazoline derivatives, Potential pharmacological activities

Downloads

Download data is not yet available.

References

1. ElShora AI. Crystal and molecular structure of 3-hydrazino-1-hydrazinothio-carbonyl pyrazoline (TNT3). Egypt J Sol. 2000; 23:251-254
2. Li JT, Zhang XH, Lin ZP. An improved synthesis of 1, 3, 5-triaryl-2-pyrazolines in acetic acid aqueous solution under ultrasound irradiation. B J Org Chem. 2007; 3:1860-5397.
3. Kelekci NG, Koyunoglu S, Yabanoglu S, Yelekci K, Ozgen O, Ucar G, Erol K, Kendi E, Yesilada A. New pyrazoline bearing 4-(3H)-quinazolinone inhibitors of monoamine oxidase: Synthesis, biological evaluation and structural determinants of MAO-A and MAO-B selectivity. Bioorg Med Chem. 2008; 22:23–25.
4. Powers DG, Casebier DS, Fokas D, Ryan WJ, Troth JR, Coffen DL. Automated parallel synthesis of chalcone-based screening libraries. Tetrahed. 1998; 54:4085-4096.
5. Havrylyuk D, Zimenkovsky B, Vasylenko O, Zaprutko L, Gzella A, Lesyk R. Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity. Eur J Med Chem. 2008; 42:1–9.
6. Sobhia HR, Yaminib Y, Esrafili A, Adiba M. Extraction and determination of 2-pyrazoline derivatives using liquid phase microextraction based on solidification of floating organic drop. J Pharm Biomed Anal. 2008; 45:316-320.
7. Eisinger J, Boens N and Flores J. Fluorescence polarization study of human erythrocyte membranes with 1-phenyl-3-(2-naphthyl)-2-pyrazoline as orientational probe. Biochim Biophysic Act. 1981; 646:334-343.
8. Li JF, Guan B, Li DX, Dong C. Study on the fluorescence properties of a new intramolecular charge transfer compound 1,5-diphenyl-3-(N-ethylcarbazole-3-yl)-2-pyrazoline. Spectrochim Act. 2007; 68:404-408.
9. Bai G, Li J, Li D, Dong C, Han X, Lin P. Synthesis and spectrum characteristic of four new organic fluorescent dyes of pyrazoline compounds. Dy Pigmen. 2007; 75:93-98.
10. Lu Z, Jiang Q, Zhu W, Xie M, Hou Y, Chen X, Wang Z. Novel pyrazoline derivative used as light emitter in blue organic electroluminescent devices. Syn Met. 2000; 111:465-468.
11. Evans NA, Rivett DE, Wilshire JFK. The chemical and photochemical properties of some 1, 3-diphenyl-2-pyrazolines. Austr J Chem. 2005; 27:2267-2274.
12. Ozdemir Z, Kandilci HBK, Gumusxel B, Unsalalısx, Bilgin AA. Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-furyl)-pyrazoline derivatives. Eur J Med Chem. 2007; 42:373-379.
13. Kucukguzel SG, Rollas S, Erdeniz H, Kiraz M, Ekinci AC, Vidin A. Synthesis, characterization and pharmacological properties of some 4-arylhydrazono-2-pyrazoline-5-one derivatives obtained from heterocyclic amines. Eur J Med Chem. 2000; 35:761−771.
14. Singh SP, Chaudhari A, Barthwal JP, Parmar SS. Anticonvulsant activity and selective inhibition of nicotinamide adenine dinucleotide-dependent oxidations by 1, 3, 5-trisubstituted pyrazolines. Wiley interscience, 1974
15. Kornet MJ, Carrett RJ. Synthesis of 1-phenyl-2-(phenylcarbamoyl) pyrazolidines as potential anticonvulsant agents. J Pharm Sci. 1979; 68:313-318.
16. Palaskaa E, Aytemira M, Uzbay IT, Erola D. Synthesis and antidepressant activities of some 3,5-diphenyl-2-pyrazolines. Eur J Med Chem. 2001; 36:539-543.
17. Prasad YR, Rao AL, Prasoona L, Murali K, Kumar PR. Synthesis and antidepressant activity of some 1,3,5-triphenyl-2-pyrazolines and 3-(2-hydroxynaphthalen-1-yl)-1,5-diphenyl-2-pyrazolines. Bioorg Med Chem Lett. 2005; 15:5030-5034.
18. Jayaprakash V, Sinha BN, Ucar G, Ercan A. Pyrazoline-based mycobactin analogues as MAO inhibitors. Bioorg Med Chem Lett. 2008; 18:6362-6368.
19. Barsoum FF, Girgis AS. Facile synthesis of bis (4,5-dihydro-1H-pyrazole-1-carboxamides) and their thio-analogues of potential PGE2 inhibitory properties. Eur J Med Chem. 2008; 15:1-6.
20. Amir M, Kumar H, Khan SA. Synthesis and pharmacological evaluation of pyrazoline derivatives as new anti-inflammatory and analgesic agents. Bioorg Med Chem Lett. 2008; 18:918-922.
21. Rathish IG, Javed K, Ahmad S, Bano S, Alam MS, Pillai KK, Singh S, Bagchi V. Synthesis and anti-inflammatory activity of some new 1,3,5-trisubstituted pyrazolines bearing benzene sulfonamide. Bioorg Med Chem Lett. 2008; 21:212-213.
22. Rani P, Srivastava VK, Kumar A. Synthesis and anti-inflammatory activity of heterocyclic indole derivatives. Eur J Med Chem. 2004; 39:449-452.
23. Kelekc NG, Yabanoglu S, Kupeli E, Salgın U, Ozgen O, Ucar G, Erdem Yesilada, Kendi E, Yesiladaf A, Bilgin AA. A new therapeutic approach in Alzheimer disease: Some novel pyrazole derivatives as dual MAO-B inhibitors and antiinflammatory analgesics. Bioorg Med Chem. 2007; 15:5775-5786.
24. Khode S, Maddi V, Aragade P, Palkar M, Ronad PK, Mamledesai S, Thippeswamy AHM, Satyanarayana D. Synthesis and pharmacological evaluation of a novel series of 5-(substituted) aryl-3-(3-coumarinyl)-1-phenyl-2-pyrazolines as novel anti-inflammatory and analgesic agents. Eur J Med Chem. 2008; 21:1-7.
25. Shoman ME, AbdelAziz M, Aly OM, Farag HH, Morsy MA. Synthesis and investigation of anti-inflammatory activity and gastric ulcerogenicity of novel nitric oxide-donating pyrazoline derivatives. Eur J Med Chem. 2008; 22:1-9.
26. Kaplancikli ZA, TuranZitouni G, Ozdemir A, DevrimCan O, Chevallet P. Synthesis and antinociceptive activities of some pyrazoline derivatives. Eur J Med Chem. 2008; 17:1-5.
27. Ozdemir A, TuranZitouni G, Kaplancıklı ZA, Revial G, Guven K. Synthesis and antimicrobial activity of 1-(4-aryl-2-thiazolyl)-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives. Eur J Med Chem. 2007; 42:403-409.
28. AbdelWahab BA, AbdelAziz HA, Ahmed EM. Synthesis and antimicrobial evaluation of 1-(benzofuran-2-yl)-4-nitro-3-arylbutan-1-ones and 3-(benzofuran-2-yl)-4,5-dihydro-5-aryl-1-[4-(aryl)-1,3-thiazol-2-yl]-1H-pyrazoles. Eur J Med Chem. 2008; 43:1-4.
29. Stirrett KL, Ferreras JA, Jayaprakash V, Sinha BN, Renc T, Quadri LEN. Small molecules with structural similarities to siderophores as novel antimicrobials against Mycobacterium tuberculosis and Yersinia pestis. Bioorg Med Chem Lett. 2008; 18:2662-2668.
30. Abunada NM, Hassaneen HM, Kandile NG, Miqdad OA. Synthesis and biological activity of some new pyrazoline and pyrrolo [3, 4-c] pyrazole-4, 6-dione derivatives: Reaction of nitrilimines with some dipolarophiles. Molecules 2008; 13:1011-1024.
31. Bhatt AH, Parekh HH, Parikh KA, Parikh AR. Synthesis of pyrazolines and cyanopyridines as potential antimicrobial agents. Ind J Chem. 2001; 40:57-61.
32. Udupi RH, Kushnoor AS. Synthesis and biological evaluation of certain pyrazoline derivatives of naproxen. Ind J Het Chem. 1998; 8:63-66.
33. Bharmal FM, Kaneriya DJ, Parekh HH. Synthesis of some pyrazoline derivatives as biologically active agents. Ind J Het Chem. 2000; 10:189-192.
34. Basawaraj R, Yadav B, Sangapure SS. Synthesis of some 1H-pyrazolines bearing benzofuran as biologically active agents. Ind J Het Chem. 2001; 11:31-34.
35. Desai J, Nair KB, Misra AN. Synthesis and antimicrobial activities of some new pyrazolines, phenyl pyrazolines, flavanones, and related compounds. Ind J Het Chem. 2001; 10:261-266.
36. Jamode VS, Chandak HS, Bhagat PR, Tambekar DH. Synthesis and antimicrobial evaluation of some 1-isonicotinoyl/carboxamido-2-pyrazolines. Ind J Het Chem. 2003; 12:323-326.
37. Shenoy GG, Bhatt AR, Bhatt GV, Kotian M. Synthesis and antimicrobial activities of 1,3,5-trisubstituted-2-pyrazolines. Ind J Het Chem. 2001; 10:197-200.
38. Mamolo MG, Zampieri D, Falagiani V, Vio L, Banfi E. Synthesis and antimycobacterial activity of 5-aryl-1-isonicotinoyl-3-(pyridin-2-yl)-4,5-dihydro-1H-pyrazole derivatives. I L Farmaco 2001; 56:593–599.
39. Ozdemir A, Asim ZG. Novel analogues of 2-pyrazoline: Synthesis, characterization and antimycobacterial evaluation. Turk J Chem. 2008; 32:529-538.
40. Shaharyar M, Siddiqui AA, MA. Synthesis and evaluation of phenoxy acetic acid derivatives as anti-mycobacterial agents. Bioorg Med Chem Lett. 2006; 16:4571-4574.
41. Zampieri D, Mamolo MG, Laurini E, Scialino G, Banfi E, Vio L. Antifungal and antimycobacterial activity of 1-(3,5-diaryl-4,5-dihydro-1H-pyrazol-4-yl)-1H-imidazole derivatives. Bioorg Med Chem. 2008; 16:4516-4522.
42. Bhat BA, Dhar KL, Puri SC, Saxena AK, Shanmugavel M, Qazi GN. Synthesis and biological evaluation of chalcones and their derived pyrazoles as potential cytotoxic agents. Bioorg Med Chem Lett. 2005; 15:3177-3180.
43. Manna F, Chimenti F, Fioravanti R, Bolasco A, Secci D, Chimenti P, Ferlini C, Scambi G. Synthesis of some pyrazole derivatives and preliminary investigation of their affinity binding to P-glycoprotein. Bioorg Med Chem Lett. 2005; 15:4632-4635.
44. Kini SG, Bhat AR, Bryant B, Williamson JS, Dayan FE. Synthesis, antitubercular activity and docking study of novel cyclic azole substituted diphenyl ether derivatives. Eur J Med Chem. 2008; 41:1-9.
45. Ali MA, Shaharyar M, Siddiqui AA. Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivatives. Eur J Med Chem. 2007; 42:268-275.
46. Babu VH, Manna SK, Sneha, Srinivasan KK, Bhatt GV. Synthesis and biological evaluation of 1, 3, 5-trisubstituted pyrazolines bearing benzofuran. Ind J Het Chem. 2004; 13:253-256.
47. Chimenti F, Bizzarri B, Manna F, Bolasco A, Secci D, Chimenti P, Granese A, Rivanera D, Lilli D, Scaltrito MM, Brenciaglia MI. Synthesis and in vitro selective anti-H. pylori activity of pyrazoline derivatives. Bioorg Med Chem Lett. 2005; 15:603-607.
48. Mogilaiah K, Sakram B. Synthesis and antibacterial activities of 1, 3, 4-oxadiazole and pyrazoline derivatives containing 1, 8-naphthyridine moiety. Ind J Het Chem. 2004; 13:289-292.
49. Vijayvergiya D, Kothari S, Verma BL. Synthesis and biological activity of some new 3,5-diaryl-1-phenyl/isonicotinoyl-2-pyrazolines. Ind J Het Chem. 2003; 13:105-110.
50. Waheed A, Khan SA. Synthesis of certain substituted 1, 2-pyrazolines from nalidixic acid as antibacterial and analgesic agents. Ind J Het Chem. 2001; 11:59-62.
51. Wanga M, Zhanga J, Liu J, Xu C, Ju H. Intramolecular energy and charge transfer in 5-(9-anthryl)-3-(4-nitrophenyl)-1-phenyl-2-pyrazoline. J Lumines. 2002; 99:79-83.
52. Jina M, Liang YJ, Lua R, Chuai XH, Yi ZH, Zhao YY, Zhang HJ. Synthesis and properties of photoluminescence and electroluminescence of pyrazoline derivatives. Syn Met. 2004; 140:37-41.
53. Svechkarev DA, Bukatich IV, Doroshenko AO. New 1, 3, 5-triphenyl-2-pyrazoline-containing 3-hydroxychromones as highly solvatofluorochromic ratiometric polarity probes. J Phot A Chem. 2008; 200:426-431.
54. Budakoti A, Bhat AR, Athar F, Azam A. Syntheses and evaluation of 3-(3-bromo phenyl)-5-phenyl-1-(thiazolo [4,5-b] quinoxaline-2-yl)-2-pyrazoline derivatives. Eur J Med Chem. 2008; 43:1749-1757.
55. Budakoti A, Abid M, Azam M. Syntheses, characterization and in vitro antiamoebic activity of new Pd(II) complexes with 1-N-substituted thiocarbamoyl-3,5-diphenyl-2-pyrazoline derivatives. Eur J Med Chem. 2007; 42:544-551.
56. Abid M, Bhat AR, Athar F, Azam A. Synthesis, spectral studies and antiamoebic activity of new 1-N-substituted thiocarbamoyl-3-phenyl-2-pyrazolines. Eur J Med Chem. 2007; 42:1-9.
57. Chimenti F, Fioravanti R, Bolasco A, Manna F, Chimenti P, Secci D, Rossi F, Turini P, Ortuso F, Alcaro S, Cardia MC. Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives. Eur J Med Chem. 2008; 43:2262-2267.
58. Silver KS, Soderlund DM. Action of pyrazoline-type insecticides at neuronal target sites. Pesticid Biochem Physiol. 2005; 81:136-143.
59. Godoy MCM, Fighera MR, Souza FR, Flores AE, Rubin MA, Oliveira MR, Zannata N, Martins MAP, Mello CF. Eur J pharmacol. 2004; 496:93-97.
60. TuranZitounia G, Chevallet P, Kilic FS, Erolc K. Synthesis of some thiazolyl-pyrazoline derivatives and preliminary investigation of their hypotensive activity. Eur J Med Chem. 2000; 35:635-641.
61. Jeong TS, Kim KS, An SJ, Cho KH, Lee S, Lee WS. Novel 3, 5-diaryl pyrazolines as human acyl-CoA:cholesterol acyltransferase inhibitors. Bioorg Med Chem Lett. 2004; 14:2715-2717.
62. Manna F, Chimenti F, Bolasco A, Secci D, Bizzarri B, Befani O, Turini P, Mondovi B, Alcaroc S, Tafid A. Inhibition of amine oxidase activity by 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives. Bioorg Med Chem Lett. 2002; 12:3629-3633.
63. Babu VH, Sridevi C, Joseph A, Srinivasan KK. Synthesis and biological evaluation of some novel pyrazolines. Ind J Pharm Sci. 2008; 69:470-473.
64. Reddy MVR, Billa VK, Pallela VR, Mallireddigari MR, Boominathan R, Gabriel JL, Reddy EP. Design, synthesis and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors. Bioorg Med Chem. 2008; 16:3907-3916.
Statistics
744 Views | 482 Downloads
How to Cite
Rahman, M. A., and A. A. Siddiqui. “PYRAZOLINE DERIVATIVES: A WORTHY INSIGHT INTO THE RECENT ADVANCES AND POTENTIAL PHARMACOLOGICAL ACTIVITIES”. International Journal of Pharmaceutical Sciences and Drug Research, Vol. 2, no. 3, July 2010, pp. 165-7, https://ijpsdr.com/index.php/ijpsdr/article/view/113.
Section
Review Article